We aimed to study the outcomes of coronavirus disease 2019 (COVID‐19) in patients with a history of rheumatoid arthritis (RA) in Iran, where most patients receive corticosteroids and are at… Click to show full abstract
We aimed to study the outcomes of coronavirus disease 2019 (COVID‐19) in patients with a history of rheumatoid arthritis (RA) in Iran, where most patients receive corticosteroids and are at high risk for COVID‐19 infection.
               
Click one of the above tabs to view related content.